Health Canada approves Biocon’s two denosumab biosimilars

Pharmaceutical Technology

Biocon has received a Notice of Compliance from Health Canada for Bosaya and Vevzuo, both biosimilars referencing Prolia and Xgeva, respectively.

RegulatoryRead full story